{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:22Z","timestamp":1787070862702,"version":"build-2736575974"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Complications in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) cause serious morbidity and mortality. Predicting patients at risk in advance and changing the symptomatic care and\/or preparation regimen according to this risk assessment have been emphasized recently. Several single-nucleotide polymorphisms have been studied, and some were found to be responsible for early complications. Glutathione S-transferase P1 (GSTP1) is an enzyme involved in the detoxification process that reduces oxidative stress by reducing the number of free oxygen radicals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study aimed to investigate the relationship between GSTP1 polymorphism and early complications of allo-HSCT, iron parameters, overall survival (OS), and transplantation-related mortality (TRM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      A total of 50 patients diagnosed with acute myeloid leukemia (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 23) or acute lymphoblastic leukemia (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 27) who underwent allo-HSCT between May 2008 and February 2011 at Gazi University Faculty of Medicine, Stem Cell Transplantation Unit, were included.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 50 patients, 24 (48%) were women and 26 (52%) were men. The median age of the patients was 26 (16\u201374) years. GSTP1 polymorphism was detected in 23 (46%) patients, and 27 (54%) had no polymorphism (wild type). The two groups were compared in terms of early toxicity after transplantation, according to the preparation regimen. The group with GSTP1 polymorphism was found to have a high transferrin saturation index (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Patients with no GSTP1 polymorphism showed a high grade III\u2013IV anemia ratio (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). The presence of sinusoidal obstruction syndrome and graft\u2013versus\u2013host disease was similar in both groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). OS and TRM were higher in the GSTP1 polymorphism group, but no statistical difference was found between the two groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>TSI was higher in the GSTP1 polymorphism group. GSTP1 polymorphism had no effect on early transplantation complications. Although the OS and TRM ratios were higher in the GSTP1 polymorphism group, no statistically significant difference was found between the groups. Further studies with larger sample size are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_61_20","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:13:21Z","timestamp":1623986001000},"page":"565-573","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Role of glutathione S-transferase P1 polymorphism in early transplant complications in patients undergoing allogeneic stem cell transplantation"],"prefix":"10.4103","volume":"17","author":[{"given":"Hazen","family":"Saritas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Suyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezen","family":"G\u00fcntekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki ahika","family":"Zeynep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"Erg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclsan Turkoz","family":"Sucak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-41-20241021","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/03630260600642575","article-title":"Glutathione S-transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with beta-thalassemia major","volume":"30","author":"Wu","year":"2006","journal-title":"Hemoglobin"},{"key":"R2-41-20241021","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/bmt.2008.262","article-title":"Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation","volume":"42","author":"Pullarkat","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R3-41-20241021","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","article-title":"Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation","volume":"109","author":"Armand","year":"2007","journal-title":"Blood"},{"key":"R4-41-20241021","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/bmt.2008.99","article-title":"Iron overload in hematopoietic cell transplantation","volume":"41","author":"Majhail","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R5-41-20241021","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbmt.2012.10.012","article-title":"Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation","volume":"19","author":"Meyer","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R6-41-20241021","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1080\/10428194.2019.1594215","article-title":"A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation","volume":"60","author":"Cremers","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"R7-41-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/tjh.2016.0450","article-title":"Current review of iron overload and related complications in hematopoietic stem cell transplantation","volume":"34","author":"Atilla","year":"2017","journal-title":"Turk J Haematol"},{"key":"R8-41-20241021","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3324\/haematol.2009.011429","article-title":"Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: A GITMO study","volume":"95","author":"Alessandrino","year":"2010","journal-title":"Haematologica"},{"key":"R9-41-20241021","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.bbmt.2008.04.009","article-title":"High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors","volume":"14","author":"Majhail","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R10-41-20241021","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12185-012-1252-1","article-title":"Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: Quantification of iron burden by determining non-transferrin-bound iron","volume":"97","author":"Goto","year":"2013","journal-title":"Int J Hematol"},{"key":"R11-41-20241021","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1703570","article-title":"Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation","volume":"29","author":"Alt\u00e8s","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R12-41-20241021","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00277-007-0266-x","article-title":"Early clinical impact of iron overload in stem cell transplantation. A prospective study","volume":"86","author":"Altes","year":"2007","journal-title":"Ann Hematol"},{"key":"R13-41-20241021","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.V95.9.2776.009k26_2776_2779","article-title":"Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload","volume":"95","author":"Franchini","year":"2000","journal-title":"Blood"},{"key":"R14-41-20241021","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2141.1997.4143221.x","article-title":"Non-transferrin-bound iron induced by myeloablative chemotherapy","volume":"99","author":"Bradley","year":"1997","journal-title":"Br J Haematol"},{"key":"R15-41-20241021","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1365-2141.2001.02820.x","article-title":"Non-transferrin-bound iron during allogeneic stem cell transplantation","volume":"113","author":"Sahlstedt","year":"2001","journal-title":"Br J Haematol"},{"key":"R16-41-20241021","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0891-5849(94)E0145-9","article-title":"Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: Possible implications for treatment related toxicity","volume":"18","author":"Gordon","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"R17-41-20241021","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbmt.2008.11.012","article-title":"Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Kataoka","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R18-41-20241021","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s11095-016-1927-z","article-title":"Iron overload exacerbates busulfan-melphalan toxicity through a pharmacodynamic interaction in mice","volume":"33","author":"Bouligand","year":"2016","journal-title":"Pharm Res"},{"key":"R19-41-20241021","first-page":"4377","article-title":"Pharmacogenetic analysis of liver toxicity after busulfan\/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Goekkurt","year":"2007","journal-title":"Anticancer Res"},{"key":"R20-41-20241021","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.beha.2008.03.004","article-title":"Polymorphisms of cytokine and innate immunity genes and GVHD","volume":"21","author":"Dickinson","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"R21-41-20241021","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.blre.2005.04.001","article-title":"Beyond the HLA typing age: Genetic polymorphisms predicting transplant outcome","volume":"19","author":"Dickinson","year":"2005","journal-title":"Blood Rev"},{"key":"R22-41-20241021","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.2004.05216.x","article-title":"Eurobank members. Genetic polymorphisms predicting the outcome of bone marrow transplants","volume":"127","author":"Dickinson","year":"2004","journal-title":"Br J Haematol"},{"key":"R23-41-20241021","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/pbc.22739","article-title":"Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation","volume":"55","author":"Elhasid","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R24-41-20241021","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/bmt.2009.143","article-title":"Influence of GST gene polymorphisms on busulfan pharmacokinetics in children","volume":"45","author":"Ansari","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R26-41-20241021","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705257","article-title":"Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipients","volume":"37","author":"Terakura","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R27-41-20241021","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.bbmt.2010.12.708","article-title":"Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation","volume":"17","author":"Kim","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R28-41-20241021","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/bmt.2012.265","article-title":"Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients","volume":"48","author":"Ansari","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R29-41-20241021","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2217\/pgs.13.159","article-title":"Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation","volume":"14","author":"ten Brink","year":"2013","journal-title":"Pharmacogenomics"},{"key":"R30-41-20241021","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/bmt.2015.321","article-title":"Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients","volume":"51","author":"Ansari","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"R31-41-20241021","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000028396","article-title":"Glutathione S-transferase polymorphisms and their biological consequences","volume":"61","author":"Hayes","year":"2000","journal-title":"Pharmacology"},{"key":"R32-41-20241021","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10937400903158375","article-title":"Genetic polymorphism in glutathione transferases (GST): Population distribution of GSTM1, T1, and P1 conjugating activity","volume":"12","author":"Ginsberg","year":"2009","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"R33-41-20241021","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","article-title":"Glutathione transferases","volume":"45","author":"Hayes","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R34-41-20241021","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/1479-7364-1-6-460","article-title":"Analysis of the glutathione S-transferase (GST) gene family","volume":"1","author":"Nebert","year":"2004","journal-title":"Hum Genomics"},{"key":"R35-41-20241021","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: A risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"Srivastava","year":"2004","journal-title":"Blood"},{"key":"R36-41-20241021","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/sj.onc.1209373","article-title":"Glutathione S-transferase polymorphisms: Cancer incidence and therapy","volume":"25","author":"McIlwain","year":"2006","journal-title":"Oncogene"},{"key":"R37-41-20241021","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.1074\/jbc.272.15.10004","article-title":"Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins","volume":"272","author":"Ali-Osman","year":"1997","journal-title":"J Biol Chem"},{"key":"R38-41-20241021","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/jhep.2002.35534","article-title":"Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism","volume":"36","author":"Henrion-Caude","year":"2002","journal-title":"Hepatology"},{"key":"R40-41-20241021","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"R41-41-20241021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bcmd.2011.03.004","article-title":"Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia","volume":"47","author":"Silva","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"R42-41-20241021","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cca.2006.06.023","article-title":"Differential expression of glutathione-S-transferase isoenzymes in various types of anemia in Taiwan","volume":"375","author":"Chiang","year":"2007","journal-title":"Clin Chim Acta"},{"key":"R43-41-20241021","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00520-006-0176-9","article-title":"Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies","volume":"15","author":"Vera-Llonch","year":"2007","journal-title":"Support Care Cancer"},{"key":"R44-41-20241021","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/leu.2008.323","article-title":"Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia","volume":"23","author":"Rocha","year":"2009","journal-title":"Leukemia"},{"key":"R45-41-20241021","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007890-199310000-00020","article-title":"Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications","volume":"56","author":"Sencer","year":"1993","journal-title":"Transplantation"},{"key":"R46-41-20241021","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0268-960X(08)70005-5","article-title":"The role of iron in patients after bone marrow transplantation","volume":"22","author":"de Witte","year":"2008","journal-title":"Blood Rev"},{"key":"R47-41-20241021","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/mcp.2002.124518","article-title":"Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: Consequences for enzyme expression and busulfan conjugation","volume":"71","author":"Bredschneider","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R48-41-20241021","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/bcpt.13185","article-title":"Effect of glutathione S-transferase genetic polymorphisms on busulfan pharmacokinetics and veno-occlusive disease in hematopoietic stem cell transplantation: A meta-analysis","volume":"124","author":"Kim","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R49-41-20241021","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"R50-41-20241021","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R51-41-20241021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1399-0039.2009.01257.x","article-title":"TNF, LTA and TGFB1 genotype distributions among acute graft-vs-host disease subsets after HLA-matched unrelated hematopoietic stem cell transplantation: A pilot study","volume":"74","author":"Shah","year":"2009","journal-title":"Tissue Antigens"},{"key":"R52-41-20241021","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.transproceed.2009.11.049","article-title":"Iron overload: Predictor of adverse outcome in hematopoietic stem cell transplantation","volume":"42","author":"Sucak","year":"2010","journal-title":"Transplant Proc"},{"key":"R53-41-20241021","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.bmt.1704628","article-title":"Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis","volume":"34","author":"Altes","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R54-41-20241021","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/10245332.1999.11746478","article-title":"Serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective cohort study","volume":"4","author":"Morado","year":"1999","journal-title":"Hematology"},{"key":"R55-41-20241021","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cca.2009.03.037","article-title":"Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation","volume":"403","author":"Wu","year":"2009","journal-title":"Clin Chim Acta"},{"key":"R56-41-20241021","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.leu.2402361","article-title":"Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: Increased early death after chemotherapy","volume":"16","author":"Naoe","year":"2002","journal-title":"Leukemia"},{"key":"R57-41-20241021","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.bbmt.2010.01.001","article-title":"A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and\/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation","volume":"16","author":"Hahn","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R58-41-20241021","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-119-3-199308010-00005","article-title":"Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years","volume":"119","author":"Marks","year":"1993","journal-title":"Ann Intern Med"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_61_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:50Z","timestamp":1787067470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_61_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_61_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}